An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 25, Issue 7, 1998, Pages 1035-1043

  Taguchi, T ^a   Morimoto, K ^a   Horikoshi, N ^a   Takashima, S ^a   Toge, T ^a   Kimura, M ^a   Sano, M ^a   Aoyama, H ^a   Ota, J ^a   Noguchi, S ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; OXONIC ACID; PYRIDINE DERIVATIVE; S 1 (COMBINATION); TEGAFUR;

ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; LEUKOPENIA; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; REMISSION; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; LEUKOPENIA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; OXONIC ACID; PYRIDINES; REMISSION INDUCTION; SURVIVAL ANALYSIS; TEGAFUR;

EID: 0032084420     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)